TY - JOUR
T1 - Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults
T2 - A randomised clinical trial
AU - Power, Rebecca
AU - Nolan, John M.
AU - Prado-Cabrero, Alfonso
AU - Roche, Warren
AU - Coen, Robert
AU - Power, Tommy
AU - Mulcahy, Ríona
N1 - Funding Information:
This research was funded by the Howard Foundation UK (UK Charity Registration Number 285822). Dr Alan Howard, founder of the Howard Foundation UK, was involved in the conceptualisation and study design of CARES.Rebecca Power: RP has performed consultancy work for MacuHealth LLC? (Birmingham, MI, USA). RP is funded in part by the Howard Foundation (registered with the Charity Commission of England & Wales #285822), hereafter ?Howard Foundation?. These organisations have an interest in commercially available supplements containing the macular carotenoids. RP is also funded by a joint research centre grant from Science Foundation Ireland (SFI) and the Department of Agriculture, Food, and Marine on behalf of the government of Ireland under grant #16/RC/3835?VistaMilk to develop commercial dairy products enriched in carotenoids. John M. Nolan does consultancy work as a Director of NOW Science Consultancy Ltd. for companies with an interest in food supplements. Alfonso Prado-Cabrero: APC has performed consultancy work for MacuHealth LLC? and the Howard Foundation. APC has also been involved in a Commercialisation Fund Programme from Enterprise Ireland to develop a biotechnological process to produce carotenoids and the fatty acids EPA and DHA. APC is currently supported by grant #16/RC/3835?VistaMilk. Robert Coen, Warren Roche and Tommy Power declare no conflicts of interest. R?ona Mulcahy does consultancy work on behalf of the Howard Foundation.
Funding Information:
Rebecca Power: RP has performed consultancy work for MacuHealth LLC™ (Birmingham, MI, USA). RP is funded in part by the Howard Foundation (registered with the Charity Commission of England & Wales #285822), hereafter “Howard Foundation”. These organisations have an interest in commercially available supplements containing the macular carotenoids. RP is also funded by a joint research centre grant from Science Foundation Ireland (SFI) and the Department of Agriculture, Food, and Marine on behalf of the government of Ireland under grant #16/RC/3835 —VistaMilk to develop commercial dairy products enriched in carotenoids. John M. Nolan does consultancy work as a Director of NOW Science Consultancy Ltd. for companies with an interest in food supplements. Alfonso Prado-Cabrero: APC has performed consultancy work for MacuHealth LLC™ and the Howard Foundation. APC has also been involved in a Commercialisation Fund Programme from Enterprise Ireland to develop a biotechnological process to produce carotenoids and the fatty acids EPA and DHA. APC is currently supported by grant #16/RC/3835 — VistaMilk . Robert Coen, Warren Roche and Tommy Power declare no conflicts of interest. Ríona Mulcahy does consultancy work on behalf of the Howard Foundation.
Funding Information:
This research was funded by the Howard Foundation UK (UK Charity Registration Number 285822 ). Dr Alan Howard, founder of the Howard Foundation UK, was involved in the conceptualisation and study design of CARES.
Publisher Copyright:
© 2021 The Authors
PY - 2022/2/1
Y1 - 2022/2/1
N2 - Background & aims: Accumulating evidence suggests that omega-3 fatty acids (ω-3FAs), carotenoids and vitamin E can improve cognitive performance. However, their collective impact on cognition has not yet been investigated in healthy individuals. This study investigated the combined effect of ω-3FA, carotenoid and vitamin E supplementation on the cognitive performance of older adults. Methods: Cognitively healthy individuals aged ≥65 years consumed daily 1 g fish oil (of which 430 mg docosahexaenoic acid, 90 mg eicosapentaenoic acid), 22 mg carotenoids (10 mg lutein, 10 mg meso-zeaxanthin, 2 mg zeaxanthin) and 15 mg vitamin E or placebo for 24 months in a double-blind, placebo-controlled, randomised clinical trial. Results: Following 24-month supplementation, individuals in the active group (n = 30; aged 69.03 ± 4.41 years; 56.7% female) recorded significantly fewer errors in working memory tasks than individuals receiving placebo (n = 30; aged 69.77 ± 3.74 years; 70% female) (point estimate effect sizes ranged 0.090–0.105). Interestingly, as the cognitive load of the working memory tasks increased, the active group outperformed the placebo group. Statistically significant improvements in tissue carotenoid concentrations, serum xanthophyll carotenoid concentrations and plasma ω-3FA concentrations were also observed in the active group versus placebo (point estimate effect sizes ranged 0.078–0.589). Moreover, the magnitude of change of carotenoid concentrations in tissue, and ω-3FA and carotenoid concentrations in blood were related to the magnitude of change in working memory performance. Conclusion: These results support a biologically plausible rationale whereby these nutrients work synergistically, and in a dose-dependent manner, to improve working memory in cognitively healthy older adults. Increasing nutritional intake of carotenoids and ω-3FAs may prove beneficial in reducing cognitive decline and dementia risk in later life. Study id number: ISRCTN10431469; https://doi.org/10.1186/ISRCTN10431469.
AB - Background & aims: Accumulating evidence suggests that omega-3 fatty acids (ω-3FAs), carotenoids and vitamin E can improve cognitive performance. However, their collective impact on cognition has not yet been investigated in healthy individuals. This study investigated the combined effect of ω-3FA, carotenoid and vitamin E supplementation on the cognitive performance of older adults. Methods: Cognitively healthy individuals aged ≥65 years consumed daily 1 g fish oil (of which 430 mg docosahexaenoic acid, 90 mg eicosapentaenoic acid), 22 mg carotenoids (10 mg lutein, 10 mg meso-zeaxanthin, 2 mg zeaxanthin) and 15 mg vitamin E or placebo for 24 months in a double-blind, placebo-controlled, randomised clinical trial. Results: Following 24-month supplementation, individuals in the active group (n = 30; aged 69.03 ± 4.41 years; 56.7% female) recorded significantly fewer errors in working memory tasks than individuals receiving placebo (n = 30; aged 69.77 ± 3.74 years; 70% female) (point estimate effect sizes ranged 0.090–0.105). Interestingly, as the cognitive load of the working memory tasks increased, the active group outperformed the placebo group. Statistically significant improvements in tissue carotenoid concentrations, serum xanthophyll carotenoid concentrations and plasma ω-3FA concentrations were also observed in the active group versus placebo (point estimate effect sizes ranged 0.078–0.589). Moreover, the magnitude of change of carotenoid concentrations in tissue, and ω-3FA and carotenoid concentrations in blood were related to the magnitude of change in working memory performance. Conclusion: These results support a biologically plausible rationale whereby these nutrients work synergistically, and in a dose-dependent manner, to improve working memory in cognitively healthy older adults. Increasing nutritional intake of carotenoids and ω-3FAs may prove beneficial in reducing cognitive decline and dementia risk in later life. Study id number: ISRCTN10431469; https://doi.org/10.1186/ISRCTN10431469.
KW - Aged
KW - Carotenoids/administration & dosage
KW - Dietary Supplements
KW - Docosahexaenoic Acids/administration & dosage
KW - Double-Blind Method
KW - Eicosapentaenoic Acid/administration & dosage
KW - Fatty Acids, Omega-3/administration & dosage
KW - Female
KW - Fish Oils/administration & dosage
KW - Humans
KW - Male
KW - Memory, Short-Term/drug effects
KW - Middle Aged
KW - Neuropsychological Tests
KW - Vitamin E/administration & dosage
KW - Zeaxanthins/administration & dosage
UR - http://www.scopus.com/inward/record.url?scp=85122471195&partnerID=8YFLogxK
U2 - 10.1016/j.clnu.2021.12.004
DO - 10.1016/j.clnu.2021.12.004
M3 - Article
C2 - 34999335
AN - SCOPUS:85122471195
SN - 0261-5614
VL - 41
SP - 405
EP - 414
JO - Clinical Nutrition
JF - Clinical Nutrition
IS - 2
ER -